CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 344 enrolled
Drug / intervention
HbA1Cother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03426228
NCT03426228N/ACompleted
CompareCT.gov

Effects of Fertility Drugs on Glucose Homeostasis and Other Metabolic Parameters on Patients Undergoing In Vitro Fertilization (IVF)

University of Warwick·observational·Posted Feb 8, 2018·Updated Jul 14, 2021

In Brief

An observational study evaluating HbA1C for GDM and 4 related conditions. Completed, enrolled 344 participants across 1 site.

Detailed Summary

A quantitative prospective cohort study will be conducted, where blood samples will be collected at different timings during the IVF protocol, to assess the impact of fertility medications on metabolic parameters of patients undergoing IVF treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGDM, Insulin Resistance, Glucose Intolerance, PCOS, Obesity
CountriesUnited Arab Emirates
CollaboratorsFakih IVF Fertility Center, University of Sharjah

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 8, 2018
Enrollment StartFeb 15, 2018
Primary CompletionAug 1, 2019
Study CompletionJan 5, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.4 years ago

Interventions

HbA1Cother

After overnight fasting, 10 ml of blood will be collected at four different timings during the IVF protocol: 1. At baseline (second day of the menstrual period) 2. Triggering phase (post-egg retrieval procedure) 3. Embryo transfer phase (post-transfer procedure) 4. Week 4 (positive bHCG) 4\. Week 8 of pregnancy